These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30059037)

  • 1. Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds.
    Sheets KT; Bagó JR; Paulk IL; Hingtgen SD
    J Vis Exp; 2018 Jul; (137):. PubMed ID: 30059037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of composite scaffold degradation rate on neural stem cell persistence in the glioblastoma surgical resection cavity.
    Moore KM; Graham-Gurysh EG; Bomba HN; Murthy AB; Bachelder EM; Hingtgen SD; Ainslie KM
    Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110846. PubMed ID: 32279815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma.
    Sheets KT; Ewend MG; Mohiti-Asli M; Tuin SA; Loboa EG; Aboody KS; Hingtgen SD
    Mol Ther; 2020 Apr; 28(4):1056-1067. PubMed ID: 32109370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma.
    Bagó JR; Pegna GJ; Okolie O; Mohiti-Asli M; Loboa EG; Hingtgen SD
    Biomaterials; 2016 Jun; 90():116-25. PubMed ID: 27016620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of Cytotoxic Mesenchymal Stem Cells with Biodegradable Scaffolds for Treatment of Postoperative Brain Cancer.
    Sheets KT; Bagó JR; Hingtgen SD
    Methods Mol Biol; 2018; 1831():49-58. PubMed ID: 30051424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tropism of mesenchymal stem cell toward CD133
    Pavon LF; Sibov TT; de Souza AV; da Cruz EF; Malheiros SMF; Cabral FR; de Souza JG; Boufleur P; de Oliveira DM; de Toledo SRC; Marti LC; Malheiros JM; Paiva FF; Tannús A; de Oliveira SM; Chudzinski-Tavassi AM; de Paiva Neto MA; Cavalheiro S
    Stem Cell Res Ther; 2018 Nov; 9(1):310. PubMed ID: 30413179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post-surgical cancer.
    Bagó JR; Pegna GJ; Okolie O; Hingtgen SD
    Biomaterials; 2016 Apr; 84():42-53. PubMed ID: 26803410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma.
    Li M; Sun S; Dangelmajer S; Zhang Q; Wang J; Hu F; Dong F; Kahlert UD; Zhu M; Lei T
    Stem Cell Res Ther; 2019 Mar; 10(1):88. PubMed ID: 30867058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.
    Graham-Gurysh E; Moore KM; Satterlee AB; Sheets KT; Lin FC; Bachelder EM; Miller CR; Hingtgen SD; Ainslie KM
    Mol Pharm; 2018 Mar; 15(3):1309-1318. PubMed ID: 29342360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence.
    Oudin A; Moreno-Sanchez PM; Baus V; Niclou SP; Golebiewska A
    BMC Cancer; 2024 Jan; 24(1):3. PubMed ID: 38166949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cells engineered to release interferon β and scFv-PD1 target glioblastoma and alter the tumor microenvironment.
    Vogiatzi I; Lama LM; Lehmann A; Rossignoli F; Gettemans J; Shah K
    Cytotherapy; 2024 Oct; 26(10):1217-1226. PubMed ID: 38852095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas.
    Kauer TM; Figueiredo JL; Hingtgen S; Shah K
    Nat Neurosci; 2011 Dec; 15(2):197-204. PubMed ID: 22197831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy.
    Carey-Ewend AG; Hagler SB; Bomba HN; Goetz MJ; Bago JR; Hingtgen SD
    Tissue Eng Part A; 2021 Jul; 27(13-14):857-866. PubMed ID: 32907497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies.
    Bajetto A; Thellung S; Dellacasagrande I; Pagano A; Barbieri F; Florio T
    Stem Cells Transl Med; 2020 Nov; 9(11):1310-1330. PubMed ID: 32543030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds.
    Compte M; Cuesta AM; Sánchez-Martín D; Alonso-Camino V; Vicario JL; Sanz L; Alvarez-Vallina L
    Stem Cells; 2009 Mar; 27(3):753-60. PubMed ID: 19096041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI tracking of polyethylene glycol-coated superparamagnetic iron oxide-labelled placenta-derived mesenchymal stem cells toward glioblastoma stem-like cells in a mouse model.
    Hsu FT; Wei ZH; Hsuan YC; Lin W; Su YC; Liao CH; Hsieh CL
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S448-S459. PubMed ID: 30198338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.
    Vieira de Castro J; Gomes ED; Granja S; Anjo SI; Baltazar F; Manadas B; Salgado AJ; Costa BM
    J Transl Med; 2017 Oct; 15(1):200. PubMed ID: 28969635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric Biomaterial Scaffolds for Tumoricidal Stem Cell Glioblastoma Therapy.
    Moore KM; Murthy AB; Graham-Gurysh EG; Hingtgen SD; Bachelder EM; Ainslie KM
    ACS Biomater Sci Eng; 2020 Jul; 6(7):3762-3777. PubMed ID: 33463324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas.
    Choi SH; Stuckey DW; Pignatta S; Reinshagen C; Khalsa JK; Roozendaal N; Martinez-Quintanilla J; Tamura K; Keles E; Shah K
    Clin Cancer Res; 2017 Nov; 23(22):7047-7058. PubMed ID: 28912136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.